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ABSTRACT

S. gordonii-PRODUCED HYDROGEN PEROXIDE MODULATES miR-663a AND
CCL20 EXPRESSION IN ORAL EPITHELIAL CELLS
The mechanisms through which a persistent recognition of commensal
bacteria by oral epithelial cells (OECs) mitigates an uncontrolled inflammatory
response of the oral mucosa remain unknown. CCL20 secretion by OECs in
response to pathogenic bacteria is regulated by S. gordonii (Sg)-induced miR663a; nevertheless, the mechanisms involved in these Sg-modulated responses
remain to be elucidated. Since Sg is a hydrogen peroxide (H2O2) producer, and
H2O2 has been shown to stimulate miRNA expression, we hypothesized that H 2O2
could be involved in Sg-induced miR663a and CCL20 responses. Expression of
miR663a was stimulated by Sg and H2O2 in a dose-dependent manner. Response
was significantly attenuated by catalase. Strong miR663a up-regulation was
associated with H2O2-producing oral streptococci. Catalase treatment rescued Aninduced CCL20 expression attenuated by Sg and Ss. Here we showed that H2O2
produced by Sg and other oral streptococcal species is involved in miR663a upregulation and regulation of CCL20 secretion by OECs. H2O2-producing oral
streptococci could represent a group of commensal bacteria contributing to
attenuating oral inflammation and dysbiosis.
Keywords: oral epithelial cells, S. gordonii, microRNA, chemokine,
hydrogen peroxide, dysbiosis
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Chapter 1: Oral Microbial Ecology
Diverse microorganisms inhabit the oral cavity and are unique to this niche
as they have evolved an exquisite specificity for oral colonization [1-3]. Within the
oral cavity, there are distinct micro-environments such as the hard non-shedding
surfaces of the teeth and the epithelial surfaces of the mucosal membranes [4]. In
addition to microbial composition, the spatial and structural organization of natural
microbial communities is being increasingly recognized as essential for physical
and metabolic interspecies interactions that can be antagonistic or cooperative [5,
6]. Gingivitis is an almost inevitable consequence of prolonged accumulation of
biofilms (plaque) on tooth surfaces; it is a controlled immune-inflammatory state
that does not permanently compromise the integrity of the tissues supporting the
teeth [4].
Under some conditions (e.g., immunodeficiencies, smoking, pathogens,
diet), the host-bacterial community interaction becomes dysbiotic and irreversible
tissue destruction of bone and gums (gingivae) occur (i.e., periodontal disease) [79]. Thus, periodontal disease is a chronic inflammatory disease triggered by
bacteria with local (i.e., tooth loss) and systemic effects (e.g., diabetes and
cardiovascular disease) if not treated. [10-12]. Periodontitis is widely regarded as
the second most common type of dental disease worldwide, following dental
caries. About 40-50% of the population in the United States has periodontal
disease in moderate and severe forms [13-15]. Therefore, a better understanding
of the host-bacteria interactions involved in oral health that prevent the transition
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from oral symbiosis to dysbiosis is needed for the development of future strategies
to prevent/treat periodontal disease.
Most of the studies related to the pathogenesis of periodontal disease have
been focused for decades in the identification of oral bacterial species associated
with disease [16]. It is currently accepted that specific oral anaerobic bacterial
species (e.g., P. gingivalis, T. forsythia, T. denticola, F. nucleatum) are causative
agents of periodontitis, based on the virulence properties and strong association
with diseased sites [17]. Thus, the microbiota associated with a healthy state is
considered more “generalist”, whereas the disease-associated microbiota is
influenced by ‘specialist’ microorganisms that possess metabolic functions and an
elevated virulence potential that are largely absent in health [18].
The distinction between pathogens and commensals is becoming
increasingly blurred, especially in diseases that ensure from the action of bacteria
that are also present in health and that involve complex host-microbe interactions,
as human periodontal disease [19]. Using whole genomic DNA probes and
checkerboard DNA-DNA hybridization, Socransky and colleagues characterized
periodontal microbial communities based on a color-coded system that reflected
cluster analysis, community ordination and associated disease severity [20]. The
convenience and appeal of the concept of “red” and other color-coded complexes
led to widespread adoption up to present day [19]. Socransky and Haffajee, et al.,
proposed that oral diseases could be better understood by focusing on the
consortia of organisms rather than on individual pathogens. They suggested that
the most pathogenic complex comprised Porphyromonas gingivalis (P. gingivalis),
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T. forsythia, and Treponema denticola in the red complex and depended on earlier
colonization of the pocket by a complex of somewhat less pathogenic organisms
[20].
As molecular-based approaches to microbe detection became increasingly
facile, and as studies, using culture-independent methodology for analysis of the
periodontal microbiota became abundant, two newer concepts emerged. First, red
complex organisms such as P. gingivalis can be found in the absence of disease,
further argument against the organisms as classical exogenous pathogens [2123]. Second, the periodontal microbiota is more heterogeneous and diverse than
previously thought [24-26], with over 700 bacterial species recognized as possible
components, of which around 200 can be present in any one individual and about
50 are present at any one site [27]. Many of these newly recognized organisms
show as good or better a correlation with disease as the classical red complex [2,
28]. Recent studies have demonstrated that specific “key” stone pathogens (e.g.,
P. gingivalis) normally found in the oral microbiota can trigger significant changes
in the abundance of bacterial species normally found in oral health, which is
defined as oral dysbiosis. Recent data from metagenomic, metatranscriptomic,
and mechanistic studies are consistent with a new model of periodontal disease
pathogenesis, which suggests that a more diverse periodontitis-associated
microbiota is involved in the disease than previously thought [1, 2, 18, 24, 29-31].
Periodontal disease results, not from individual pathogens but rather from
polymicrobial synergy and dysbiosis, which perturb the ecologically balanced
biofilm association with periodontal tissue homeostasis [19, 32, 33].
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According to Nishihara and Koseki, the conversion from periodontal health
to disease is accompanied by a shift in indigenous microflora of plaque biofilm from
gram-positive facultative bacteria to gram-negative microorganisms [34]. It is now
recognized that a pathogenic/dysbiotic biofilm is a prerequisite for periodontitis to
develop but is insufficient to cause the disease. The disease results from complex
interactions between the biofilm and the inflammatory immune response, and it is
the latter that is estimated to account for almost 80% of the risk of periodontal
tissue damage [35, 36]. A common change in the oral microbiota in diseased sites,
gingivitis, and periodontitis, is a decrease in the proportions of health-associated
bacteria such as Streptococcus and an increase in anaerobic proteolytic bacteria,
P. gingivalis, T. forsythia, and T. denticola [1, 19].
Of note, despite there being significantly higher numbers of commensal
bacteria in the microbial ecology, and even biofilms at the sites of periodontal
lesions, significantly fewer studies have emphasized the important role of
commensal bacterial species in maintaining oral health or contributing to a disease
process. The mechanisms through which the oral epithelial inflammatory
responses to commensal bacteria are regulated to maintain homeostasis and
mitigate breakdown of the epithelial barrier and further tissue inflammation and
damage remain unclear.

4

Chapter 2: Dysbiosis
It has been recently demonstrated that a variation in the abundance of
bacterial species normally observed in oral health (i.e., dysbiosis), is a critical step
for the development of oral pathologic inflammation in periodontal disease [19].
Factors that can enhance oral dysbiosis could be environmental factors (e.g.,
smoking), host factors (e.g., diabetes), and specific pathogens (e.g., P. gingivalis).
The relation between dysbiosis and oral inflammation suggests that there could be
oral bacterial species that play a critical regulatory role of inflammation to maintain
homeostasis. This could be directly modulating the abundance of other pathogenic
bacterial species through antibacterial mechanisms (e.g., bacteriocins) or
indirectly modulating host mucosal inflammatory responses. Nevertheless,
identification of such anti-inflammatory oral bacterial species and the potential
cellular and molecular mechanisms involved in regulating inflammation remain to
be determined.
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Chapter 3: Hydrogen Peroxide-Producing Streptococcus
The genus Streptococcus is the most abundant in the salivary microbiome,
regardless of the geographic origin of the saliva sample, and accounts for 22.7%
of all

sequences detected

during

microbiome

sequencing

[37].

For

example, Streptococcus salivarius (S. salivarius), Streptococcus sanguinis (S.
sanguinis), Streptococcus

parasanguinis

(S.

parasanguinis),

Streptococcus gordonii (S. gordonii), and Streptococcus australis (S. australis) are
found on multiple soft surfaces within the cavity. In contrast, Streptococcus
intermedius (S. intermedius) and Streptococcus constellatus (S. constellatus) are
associated with dental plaque on tooth surfaces and their presence is implicated
in the development of periodontal diseases [20].
The mitis group of streptococci, a group of early oral colonizers usually
precedes the multiplication of the predominately gram-negative, biofilm producing
colonizers [38-40]. Primary colonizers of the mitis group streptococci have adhesin
molecules that recognize and bind to complementary salivary receptors that
provide receptors for secondary colonizers, later forming biofilms [40, 41]. Other
bacterial

species

of

mitis

group

include

specialized

pathogens

such

as Streptococcus pneumoniae (S. pneumoniae), and less pathogenic streptococci
like Streptococcus mitis (S. mitis), Streptococcus oralis (S. oralis), S. sanguinis,
or S. gordonii [42].
A feature of streptococcal species of the mitis group is that produce
hydrogen peroxide (H2O2), which is considered to play an important role on
bacterial competition in microbial communities [43, 44].
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H2O2 is the simple

peroxide, and stronger oxidizer, which is linked to its cytotoxic and tissuedamaging effects [45, 46]. The cytotoxicity and tissue damaging effects of H 2O2
may be associated with pathogenic properties of the mitis group of streptococci.
Therefore, it is likely that streptococcal H 2O2 enables bacteria to escape from
macrophage phagocytosis, and damages epithelial barriers, thereby contributing
to bacterial dissemination [47]. S. gordonii and S. sanguinis are members of the
mitis oral streptococci that produce H2O2 as a competition mechanism to keep
microbiota homeostasis and fight against foreign pathogens from growing [48].
Streptococcus mutans (S. mutans) and S. salivarius are also members of the oral
commensal bacteria, and they do not produce H2O2 [47, 49]. H2O2 is better known
for its cytotoxic effects, in recent years it has become established as an important
regulator of eukaryotic signal transduction [50]. H2O2 is generated in response to
various stimuli, including cytokines and growth factors, and is involved in regulating
biological processes as diverse as immune cell activation and vascular remodeling
in mammals [51, 52].
H2O2-producing streptococcus contain the pyruvate oxygenase gene
(spxB). SpxB-dependent H2O2 generation is conserved among most of the oral
streptococci and is typically expressed as a single gene controlled by its own
promoter [53].

When comparing the aerobic growth of H 2O2 -producing

streptococci in the presence and absence of externally added catalase, it is evident
that H2O2 production yields self-toxicity [54]. The absence of catalase or other
commonly employed H2O2 detoxifying enzymes in oral streptococci also suggests
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that other important, perhaps uncharacterized; mechanisms are involved in
protection from H2O2 toxicity [53].
Okahashi et al., demonstrated that H2O2 acts as a cytotoxin that contributes
to the virulence of the mitis group of streptococci [47]. Likewise, some bacterial
species such as Actinomyces naeslundii (A. naeslundii) can produce catalase, a
H2O2-decomposing enzyme, which has been shown to reduce oral epithelial cell
death [47]. There is a considerable variation among cell types in the concentration
of exogenous hydrogen peroxide required to initiate a particular biological
response. For example, the concentration of hydrogen peroxide required to cause
apoptotic cell death of mammalian cells can vary as much as 20-fold, depending
on the cell type [55-57].

Recent studies in mammalian cells have revealed

concentration-specific responses to H2O2. For example, different patterns of p53regulated gene expression are initiated in response to different H2O2 levels (0.2
mM, 0.4 mM, and 1 mM) , antioxidants are induced in response to low levels of
H2O2, where they lower the reactive oxygen species (ROS) levels and hence,
protect the cell from DNA damage, while higher levels also stimulate the
expression of pro-oxidants involved in apoptosis [57].
H2O2 is now thought to influence signaling pathways that modulate some
proinflammatory responses [58-60]. A study conducted by Okahashi et al., found
that infection with viable S. oralis, a H2O2 producer, or exposure to 1 mM H2O2
induced IL-6 production in epithelial cells. IL-6 is a pleiotropic pro-inflammatory
cytokine that acts on various cells [61, 62] that promotes the differentiation of Band T-cells, thus amplifying immune and inflammatory responses [47]. Several
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studies have demonstrated that subtoxic levels of H 2O2 and other ROS stimulate
the production of IL-6 in epithelial cells [58, 63, 64]. Hydrogen peroxide is thought
to differentially regulate the expression of IL-6 and β-defensin 2 in epithelial cells
[47]. Oral mitis group of streptococci can stimulate cytokine and defensin
productions in epithelial cells [65-67]. Ji, S., et al. reported that viable S. sanguinis
enhanced IL-1alpha production in human gingival epithelial cells. They showed
that S. sanguinis did not induce β-defensins and cathelicidin expression [65].
Hasegawa, Y., et al. described that viable S. gordonii inhibits IL-6 and IL-8
secretion from gingival epithelial cells [66]. Infection with these oral streptococci
seem to evoke multiple effects on epithelial cells including the cytotoxicity of H2O2
[47].
Beyond the conventional view of ROS as drivers of inflammation, it has
been recently demonstrated that H2O2 released by streptococcal species inhibits
the inflammasomes-dependent innate immunity as a mechanism that bacteria
could use to restrain the immune system to co-exist with the host [68].
Inflammasomes are vital players in the eradication of bacterial pathogens [69-71].
Inflammasomes are intracellular multiprotein complexes that control the activation
of Caspase-1, mediating pyroptotic cell death and the maturation of IL-1 family
cytokines that are essential for optimal defense against pathogens [69, 71].
Generally, inflammasome activation involves two checkpoints: a priming step to
induce the synthesis of pro-IL-1β and certain inflammasome components and a
second step triggering the assembly and activation of inflammasome complexes
[72].
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Correspondingly, recent studies also reveal that an increasing number of
pathogens are equipped with mechanisms to circumvent inflammasome activation
[73-75]. Such pathogens can overcome inflammasome-dependent host defenses
either by evading receptor recognition or though active mechanisms of
inflammasome suppression [74].

The active mechanisms on inflammasome

suppression reported thus seem to require an intimate host-pathogen contact to
permit the delivery on inhibitory effectors into the host cells [73-75]. Arguably, such
directed delivery of virulence factors is probably essential to ensure that immune
suppression is not global but only limited to the infected and not the healthy
bystander cells [68].
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Chapter 4: Macrophage Inflammatory Protein-3 Alpha (MIP3α)
Oral dysbiosis normally leads to an inflammatory response in the gingival
tissue through the activation of prostaglandins, cytokines, and chemokines [76,
77]. The levels of the pro-and anti-inflammatory cytokines in specific sites and at
various time points, affect the control of initiation, progression, and inhibition of
inflammation [78]. Chemokines are also involved in both physiology and pathology
of bone metabolism as chemokines are essential signals for trafficking osteoblast
and osteoclast precursors as well as act as potential modulators of bone
homeostasis [79, 80]. Epithelial cells are the first cell type encountered by oral
bacteria that normally produce cytokines and chemokines early during the initiation
of periodontal disease. These inflammatory mediators are increased later in the
progression of the disease when lymphocytes infiltrate the established and
advanced lesion [81].
Macrophage Inflammatory Protein 3 Alpha (MIP-3α) (also known as
chemokine ligand 20-CCL20), is a chemokine that is secreted by a broad spectrum
of cells and tissues, including lymph nodes, appendix, liver, lungs, and endothelial
cells and its production can be induced by IL-1β, TNF- α, INF-γ as well as LPS
[82]. CCL20 has been shown as critical marker of innate immune responses
against microbial invasion [83, 84].

It has been previously reported, that P.

gingivalis and F. nucleatum are excellent inducers of human CCL20 [85, 86]. In a
clinical experiment conducted by Hosokawa, Nakanishi, et al., showed via RT-PCR
that periodontally inflamed gingival tissue, expresses MIP-3α mRNA and
immunohistochemical staining revealed MIP-3α expression on basal layer of
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gingival epithelial cells, microvascular endothelial cells, and dense inflammatory
cell areas in periodontal disease sections [87]. MIP-3𝛼-expressing gingival
epithelial cells colocalized with gingival-infiltrating T cells, as well as gingivahoming CD4+ T cells from periodontal disease, suggesting chemotaxis effect of
MIP-3α. Consistently, the same authors showed low MIP-3α expression in healthy
gingival tissue.
C-C chemokine receptor type 6 (CCR-6), a known receptor of CCL20 [88]
is expressed by a variety of cells of the innate and/or adaptive immune system, in
particular T-helper 17 (Th17) cells, which exert multiple functions via release of
cytokine IL-17A in many chronic inflammatory disorders (e.g., atherosclerosis)
[89]. Under inflammatory conditions, epithelial cells are thought to be important
sources of CCL20 production [88, 90, 91]. According to Liao F, et al., and Dieu
MC, et al., CCR6 is the only known receptor for MIP-3𝛼 (CCL20) that is
chemotactic for lymphocytes and dendritic cells [92, 93]. Previous studies indicate
that CCR6 receptors are expressed on memory T cells and immature dendritic
cells, where they are infiltrated, as well as ligand MIP-3α, attaches to memory T
cells from the adaptive immune system in periodontal disease tissues [92-95].
CCR-6 is expressed on immature dendritic cells, whereas its expression is lost
during their maturation [93]. Furthermore, CCR-6 is present on naïve and memory
B cells, but not on germinal center B cells [96] and is also expressed on a small
fraction of memory T cells [92].

The expression of CCR-6 has been tightly

associated with IL-17 and/or IL-22-producing T cells, referred to as Th17 and Th22
cells [97-101]. Results from experimental animal models have shown that CCR-6
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and CCL20 play an important role in the migration of Th17 to inflamed sites in vivo
[102, 103].
Studies have shown that IL-17A (cytokine IL-17, hallmark of Th17 cells)
[104] can stimulate epithelial, endothelial, and fibroblastic cells to produce IL-6, IL8, and prostaglandin E2 [105].

It is suggested that IL-17A can induce

osteoclastogenesis due to induction of receptor activator of nuclear kappa-B ligand
(RANKL) on osteoblastic cells, related to osteoclastic bone resorption activity in
periodontal diseases [106, 107]. Similarly, it has been shown that Th17 cells
exacerbate inflammatory periodontal disease by activating adjacent cells to
produce inflammatory mediators.

This in turn generates a positive loop for

amplification of the inflammatory reaction that results in more tissue destruction
[108]. Early studies implicated IL-23 in driving Th17 differentiation, it is now clear
that TGF-β, IL-6, IL-1, and IL-21 are the key cytokines involved in Th17
differentiation, whereas IL-23 is required for Th17 cell expansion, survival, and
pathogenicity [109-111].
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Chapter 5: Micro RNAs (miRNAs)
According to Millar et al., miRNAs are 21-to 23- nucleotide noncoding RNA
molecules that are involved in almost all aspects of eukaryotic life, as well as a
regulator for biological processes in cross-coordination and functional integration
of complex physiological events [112]. Most miRNAs function as gene expression
regulators via silencing mechanisms and mRNA cleavage and post-translation
repression through RNA-induced gene silencing complex (RISC) [113] and this
silencing mechanism is dependent on the complementary level between miRNA
and mRNA target [114].

miRNAs are also involved in up-regulating gene

expression [115], meaning that miRNAs can regulate and be regulated by target
interactions with mRNA that suggests they play a vital role in physiological
interactions and disease processes [116].
Recent studies have shown that miRNAs play roles in the homeostasis of
periodontal tissue, stem cell differentiation, osteoblast and osteoclast function as
well as serves as a response to mechanical stress in the periodontium [117, 118].
The breakdown of the periodontal connective tissue and surrounding alveolar bone
are governed by many factors, including microRNAs (miRNAs) that regulate bone
formation, resorption, remodeling, repair, and disease [119].

Despite that

evidence, the role of miRNAs in oral health and periodontitis remains unknown.
Dysregulation of miRNA expression in tissues is reflected in biofluids, such as
serum, saliva and crevicular fluids of the gingiva [120, 121]. Therefore, miRNAs
may be used as specific and sensitive biomarkers indicative of many diseases.
The involvement of miRNAs in various stages during host response against
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bacterial infections is highly dependent on the cellular context, with different cell
types responding differently to the same pathogen [122]. Recently, several human
subject studies have also compared miRNA expression profiles between healthy
and diseased gingival tissues [123-126] or healthy and obese subjects [127].
These profiling studies demonstrated that periodontal disease resulted in a
changed miRNA expression pattern in diseased tissues. Changes in miRNA levels
affect both primary and secondary immune responses of the host against bacterial
infection in periodontal tissue.
At present, the most common oral fluid-based molecular biomarkers for
periodontitis fall into three general categories: host derived enzymes and their
inhibitors, inflammatory mediators and host response modifiers, and tissue
breakdown products [128-131]. Most recently, miRNAs have emerged as a novel
class of highly sensitive and specific biomarkers.

miRNAs remain stable in

extracellular fluids due to their packaging and the thus ideally suited to serve as
non-invasive biomarkers for periodontal disease [132-134]. While immune cells
and non-immune cells synthesize miRNAs intracellularly, they also actively release
miRNAs into extracellular environments, including extracellular fluids [135-137].
The released miRNAs are associated with RNA binding proteins or high-density
lipoproteins, or they are enclosed within lipid vesicles. They are highly stable in
extracellular fluids [138]. Five miRNAs, including miR-142-3p, miR-146a, miR155, miR-203, and miR-223, have been proposed as markers for periodontal
disease [139]; however miRNAs contributing to oral health remain to be identified.
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Our lab has recently identified miR-663a up-regulated in human oral
epithelial cells exposed to the oral streptococcal commensal bacterium S. gordonii.
Interestingly, miR-663a inhibited oral pathogen-induced CCL20 expression. This
is relevant given the significant role of CCL20 regulating Th17 responses, which
are strongly linked to soft and bone tissue destruction in periodontal disease. Other
studies have shown that Hydrogen peroxide can up-regulate miRNAs expression
and S. gordonii is H2O2-producing bacteria [47, 140]. Therefore, we hypothesized
that hydrogen peroxide produced by S. gordonii modulates miR663a expression
and CCL20 production in oral epithelial cells (Figure 1).

Figure 1 The oral commensal S. gordonii (Sg) induces the expression of miR-663a
in oral epithelial cells.
MiR-663a reduce oral pro-inflammatory/A. naeslundii-induced CCL20 expression,
likely through regulation of the transcription factor JunB.
However, the
mechanisms through which Sg activates miR-663a expression and regulates
CCL20 expression remain unknown.
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Chapter 6: Materials and Methods
6.1 Oral Epithelial Cell Culture
The immortalized oral keratinocyte cell line OKF6/hTERT (OKF6) was used
and grown in serum-free keratinocyte medium (Ker-SFM, Gibco, Carlsbad, CA)
supplemented with 25 µg/mL bovine pituitary extract and 0.2 ng/mL human
recombinant epidermal growth factor as previously done (Al-Attar et al., 2018;
Dickson et al., 2000). OKF6 cells were incubated at 37°C in 5% Carbon dioxide
(CO2) and cell growth was monitored through an inverted microscope (Nikon
Eclipse TI-S, Japan).
To subculture cells, the old medium was removed and OKF6 cells were
washed with sterile 1x PBS (Gibco, Canada). After the removal of PBS, 3 mL
Trypsin-EDTA (Gibco, Canada) were added to the culture flasks and incubated for
8 minutes at 37°C in 5% CO2 to detach the cells. Detachment was monitored by
inverted microscopy. Further, 6 mL of DMEM supplemented with 10% fetal bovine
serum (FBS) (Gibco, Canada) were added to inactivate trypsin. Cell suspension
was then transferred into a sterile 15 mL tube (Sigma, Darmstadt, Germany) and
centrifuged for 6 minutes at 1000 rpm (Sorvall RT6000B Refrigerated Centrifuge).
Supernatant was discarded, and cell pellet was re-suspended in Ker-SFM medium
with supplements for further cell culture and experiments.
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6.2 Bacterial cell cultures
Four streptococcal species abundantly found in the oral microflora were
used in these studies: two hydrogen peroxide producers (Streptococcus gordonii
ATCC 10558 and Streptococcus sanguinis ATCC 100556) and two non-hydrogen
peroxide producers (Streptococcus mutans ATCC 25175 and Streptococcus
salivarius ATCC BAA-2593). Actinomyces naeslundii (ATCC 12104D-5), grown in
an anaerobic chamber, was also used as positive control for CCL20 induction in
OECs. All bacteria were grown on blood agar plates (BBL, Benton, Dickinson and
Company, USA) at 37°C with 5% CO2 for 24 hours. Then colonies were inoculated
in 4mL of brain-heart infusion (BHI) medium (Brain heart infusion, BD; Yeast
extract, BD; L-cysteine, Sigma; Hemin, Sigma; Vitamin K; Sigma) and cultured
under the same conditions overnight (12-24h) to reach exponential growth.
Bacterial growth was monitored by determination of optical density (OD) (Beckman
Coulter, DU 530 Life Science UV/Vis Spectrophotometer). Bacteria diluted 1:50 in
BHI broth was counted using a microscope (Olympus BX-41, B&B Microscopes
Limited) and a hemocytometer, to adjust bacterial cell suspensions for OKF6 cell
challenge experiments.
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6.3 miR-663a expression analysis by qPCR.
We first evaluated the effect of hydrogen peroxide (H2O2) in the expression
of miR-663a by OKF6 cells. Cells exposed to S. gordonii (1:5) or incubated only
with Ker-SFM were used as a positive and negative controls. OKF6 cells
(1x105/well) in 1 mL of Ker-SFM were seeded in 24-well plates overnight. Then,
cells were treated with different concentrations of H 2O2 (0.1, 0.5, and 1mM)
(Sigma, Darmstadt, Germany) or infected with S. gordonii MOI 1: 5 for 24 hours.
Then, supernatants were removed, and miRNA isolation performed using the
miRNeasy Mini Kit (Qiagen, Germantown, MD, USA). Briefly, cells were lysed with
Trizol (QIAzol) (Qiagen, Germantown, MD, USA) and placed in 1.5 mL tubes,
homogenized, and incubated at room temperature for 5 minutes. Chloroform,
minimum 99% (Sigma, Darmstadt, Germany) was added to the homogenized
mixture and shaken vigorously for 15 seconds, incubated at room temperature for
3 minutes, and then centrifuged at 12,000 x g for 12 minutes at 4°C. The upper
aqueous phase was collected, and 1.5 volumes of 100% ethanol (Fisher
BioReagents, USA) were added to the mix to further disrupt any bound RNA
fragments. The mixture was transferred into a collection tube provided by the
miRNeasy kit and centrifuged at 8000 x g for 15 seconds to collect all the RNA
from the sample, the waste was removed. Buffer RWT (Qiagen, Germantown, MD,
USA) was added to the collection column to purify the miRNA sample and
centrifuged for 15 seconds at 8000 x g. Buffer RPE (Qiagen, Germantown, MD,
USA) was added to the collection column to wash off membrane-bound RNA and
centrifuged twice (for 15 seconds and 2 minutes at 8000 x g) to ensure the

19

complete removal of total RNA samples from the membrane in the column. Then
the mixture was added to a new collection tube and centrifuged at full speed for 1
minute. This mixture was then placed in a 1.5 mL collection tube and 30µL RNAsefree water (Qiagen, Germantown, MD, USA) was added to the membrane directly
and centrifuged to elute the samples off the membrane into the flow through liquid.
The concentration of total RNA and purity was checked using Thermo Scientific
NanoDrop 1000 (Thermo, Waltham, MA).

Concentration of total RNA was

analyzed using a NanoDrop software and the ratios of A260/A280 of total RNA
1.9-2.0 to ensure good quality. Expression analysis of miR-663a was performed
using miRCURY RNA miRNA PCR Starter Kit (Qiagen, Germantown, MD, USA).
To prepare the cDNA, the total RNA samples were diluted to 5 ng/µL using RNAsefree water (Qiagen, Germantown, MD, USA). The reverse transcriptase reactions
were prepared over ice. The MIX buffer solutions used were 2 µL 5x miRCURY
RT Reaction Buffer (Qiagen, Germantown, MD, USA), 4.5 µL RNAse-free water,
1 µL 10x miRCURY RT Enzyme Mix (Qiagen, Germantown, MD, USA), and 0.5
µL UniSp6 RNA spike-in (Qiagen, Germantown, MD, USA) to make a total volume
of 8 µL MIX, plus 2 µL Template (sample) volume to equal out to 10 µL. The
primary purpose of UniSP6 spike-in and the matching primer is used as an interplate calibrator to act as a synthetic control template for the quality, cDNA
synthesis and PCR amplification for miRCURY. The samples were then placed in
a Thermocycler (Eppendorf Mastercycler, USA) and reverse transcription
performed incubating samples for 60 minutes at 42°C, 5 minutes at 95°C to heat

20

inactivate the reverse transcriptase, and immediately cooled to 4°C. The samples
were stored at 4°C.
For the qPCR reaction, the cDNA samples were diluted 1:60 using RNAsefree water. The reaction mixture was then prepared by adding 5 µL 2x miRCURY
SYBR Green Master Mix (Qiagen, Germantown, MD, USA), 0.5 µL PCR Primer
mix, specific for miRNAs (Qiagen, Germantown, MD, USA), 3 µL cDNA template
(Qiagen, Germantown, MD, USA), and 1 µL RNAse-free water per sample. The
mixture was then vortexed to homogenize the solution and then 7 µL of Mix and 3
µL of sample were pipetted into a 96-well PCR plate (Qiagen, Germantown, MD,
USA). The plate was then centrifuged at room temperature for 2 minutes and then
was placed in the thermocycler for analysis (LightCycler480, Roche, Basel,
Switzerland). PCR initial heat activation for 2 minutes at 95°C, a two-step cycle of
denaturation for 10 seconds at 95°C and combined annealing/extension for 60
seconds at 56°C for 40 independent cycles. The melting curve analysis was
between 60 and 95°C. Concentration ratios for the target miRNAs were calculated
by normalizing to the endogenous control miR103a-3p, a commonly used miRNA
reference, or house-keeping gene will not be affected during the reactions, [141]
using the 2-ΔΔCT method.
Evaluation of the effect of oral streptococcal species hydrogen peroxide
producers or non-producers in miR-663a expression by OKF6 cells were similarly
evaluated. Briefly, OKF6 cells were exposed to low (MOI 1:5) or high (MOI 1:50)
bacteria concentrations of either H2O2-producers (S. gordonii and S. sanguinis) or
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non-H2O2-producers (S. mutans and S. salivarius) for 24h and miR-663a
expression evaluated through qPCR as described above.
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6.4 Effect of catalase in rescuing A. naeslundii-induced CCL20 expression
inhibited by S. gordonii and S. sanguinis.
Protocol for this experiment follows the ELISA MAX TM Deluxe Set Human
CCL20 (MIP-3alpha) Protocol (BioLegend, San Diego, CA). OKF6 cells (1x105
cells/well) in 1 ml Ker-SFM medium with supplements were seeded in a 24-wells
plate (SPL Cell culture plate, Korea) overnight. Then, OKF6 cells were exposed to
A. naeslundii MOI 1:50 in presence of S. gordonii or S. sanguinis (MOI 1:5), with
or without catalase (10 or 100 units) for 24 hours, and supernatant collected and
stored in labelled centrifuge tubes on ice. Cells were then washed twice with 1mL
ice cold 1x PBS, treated with 300 µL RIPA Buffer with proteinase inhibitor, placed
on an orbital shaker over ice for 20 minutes (500 rpm with a 0.3 cm circular orbit),
scraped from the 24-well plate and pipetted into a labelled centrifuge tube for
centrifugation (cell lysates: 14,000 rpm in 4°C for 15 minutes; supernatants: 5000
rpm at 4°C for 5 minutes). Clear supernatant was collected into a new centrifuge
tube and immediately placed in -20°C while the pellet was discarded. Supernatants
were normalized to total volume and cell lysates were normalized to total protein.
For CCL20 determination, 100 µL diluted Capture Antibody solution was added to
each well in a 96 microwell plate (BioLegends) and placed in 4°C overnight. The
96-well microwell plate was then washed 4x using 300 µL Wash Buffer, blocking
the plate with 200 µL 1X Assay Diluent A (BioLegends), sealing the plate and
incubating at room temperature (RT) on a plate shaker for one hour. After 4
washes with Wash Buffer, 50 µL 1X Assay Diluent A (BioLegends) were added to
the wells, followed by addition of 50ul of recombinant CCL20 standards or
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supernatant or cell lysate samples. Plate was incubated at RT for 2 hours. Cell
lysates were diluted 1:9 with 1X Assay Diluent A (BioLegends) before analysis
After washes, 100 µL Detection Antibody solution (BioLegends) were added
into each well and plate incubated at RT for one hour. Finally, 100 µL diluted
Avidin-HRP solution (BioLegends) were added to each well, incubated for 30
minutes, washed five times, and 100 µL Substrate Solution F (BioLegends) added
to each well. Plate was incubated in the dark for 15 minutes and reaction stopped
by adding 100 µL Stop Solution (sulfuric acid, 2N H2SO4) to each well. Plate was
read with a spectrophotometer (Molecular Devices, SpectraMax M2) at an
absorbance at 450 nm and 570 nm. (SoftMax Pro 7 version 7, Data Acquisition
and Analysis Software, Molecular Devices).
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6.5 Cell viability
OKF6 cells (1x105 cells/well) in 1 ml Ker-SFM medium with supplements
were seeded in a 24-wells plate (SPL Cell culture plate, Korea) overnight. After
different treatments with bacteria, OKF6 cells were monitored using inverted
microscope (Nikon). Then, culture media was removed, OKF6 cells washed three
times with 1xPBS and trypsinized as described above. Cells were then transferred
to 1.5 mL tubes for centrifuging. (Microfuge 20R, Beckman Coulter, Germany). Cell
pellets were resuspended in Ker-SFM and counted using trypan blue staining in a
1:1 ratio using Lifestyle Cell Counting (Countess II, Life Technologies). The total
concentration and percent (%) of alive cells were recorded using Excel
spreadsheet.
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6.6 Statistical Analysis
To account for heterogeneity of variance across treatment groups and
potential correlation among samples taken from the same experiment, linear mixed
models were fit for each outcome variable to test for differences across treatment
groups. Random effects were included for wells and adjustments were made to
account for differences across experiments, as necessary. In addition, a log
transformation was used to help stabilize the variance across treatment groups.
For models containing a significant overall fixed effect for treatment, pairwise
comparisons and/or subset mixed models were run, as appropriate. KenwardRoger adjustments were used to correct for negative bias in the standard errors
and degrees of freedom calculations induced by small sample sizes. Across all
analyses, a p-value of less than 0.05 was considered significant. All analyses were
completed in SAS 9.4 (SAS Institute Inc.; Cary, NC, USA).
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Chapter 7: RESULTS
7.1 Effect of H2O2 on miR-663a expression
We first determined if miR-663a expression could be up-regulated by
hydrogen peroxide (H2O2) in oral epithelial cells (OKF6). All tested H 2O2
concentrations induced higher miR-663a expression levels when compared with
unstimulated cells (Control), although only 0.5 and 1 mM reached significance
(Figure 2). Expression levels of miR-663a induced by H2O2 were about 6-fold
higher compared with the effect of S. gordonii.
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7.2 Effect of catalase in S. gordonii-induced miR-663a expression in oral
epithelial cells.
To determine if H2O2 produced by S. gordonii was involved in miR-663a
expression in oral epithelial cells, we exposed OKF6 cells to S. gordonii (Sg) [1:5]
in presence or absence of the enzyme catalase and miR-663a expression
determined as described in methods. As expected, a robust miR-663a expression
was observed in cells exposed to Sg. Interestingly, this response was attenuated
by presence of Catalase, especially at higher concentrations (100U). Similarly,
H2O2 treatment increased miR-663a expression and catalase significantly reduced
this response, which supports appropriate enzymatic activity in the used
experimental conditions. (Figure 3).
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7.3 Effects of oral streptococcal species in miR-663a expression.
Oral streptococci are one of the most abundant species in the oral
microbiome. Species that belong to the streptococcal group mitis (e.g., S. gordonii,
S. sanguinis), are recognized as oral bacteria with the ability to produce higher
amounts of hydrogen peroxide as a mechanism of defense to kill or inhibit growth
of other bacteria within microbial communities [37, 42-44]. To test the hypothesis
that other oral streptococcal species producers of hydrogen peroxide could also
enhance miR-663a expression in oral epithelial cells, oral epithelial cells were
exposed to selected oral streptococci producers of H 2O2 (i.e., S. gordonii and S.
sanguinis) and non-H2O2 producers (i.e., S. mutans and S. salivarius). A significant
dose-response increase in miR-663a expression was observed in cells exposed
to S. gordonii and S. sanguinis but not to S. mutans and S. salivarius, when
compared with mock unstimulated cells (Figure 4).
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7.4 Effect of catalase in CCL20 expression inhibited by S. gordonii and S.
sanguinis.
Our group recently found that miR-663a induced by S. gordonii in oral
epithelial

cells

can

reduce

CCL-20

secretion

induced

by

oral

pro-

inflammatory/pathogenic bacteria (e.g., A. naeslundii and F. nucleatum). Since the
above results show that H2O2 producing streptococcal species impact miR-663a
expression in OKF-6 cells, we hypothesized that catalase would rescue bacteriainduced CCL20 secretion inhibited by S. gordonii. As previously observed by our
group, only oral epithelial cells exposed to A. naeslundii secreted significant
amounts of CCL20 into supernatants but not S. gordonii or S. sanguinis (Figure
5A). Consistently, challenge of oral epithelial cells with A. naeslundii in presence
of S. gordonii or S. sanguinis secreted significantly lower amounts of CCL20.
Nevertheless, presence of higher concentrations of catalase increased A.
naeslundii-induced CCL20 levels in supernatants that were inhibited by S.
gordonii. Similar effect was observed with S. sanguinis, although increased CCL20
secreted levels were not significantly different from levels induced by A. naeslundii
and S. sanguinis only in media. (Figure 4A). Evaluation of CCL20 levels in cell
lysates in response to similar treatments showed comparable results of what was
observed with supernatants (Figure 5B).
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7.5 Cell viability of oral epithelial cells in response to bacterial and hydrogen
peroxide treatments.
In general, the oral streptococcal species S. gordonii, S. salivarius and S.
mutans, did not significantly affect the cell viability of oral epithelial cells (OECs) at
the tested concentrations after 24 h of challenge. Only higher MOI (1:50) of S.
gordonii and S. mutans reduced about 20% cell viability (Figure 6A). However, S.
sanguinis significantly reduced cell viability about 30-50% at MOIs between 1:1
and 1:10. Higher MOI of S. sanguinis (1:50) reduced about 60% cell viability of
OECs (Figure 6A). OECs exposed to H2O2 concentrations that enhanced miR663a expression showed dose-response decreased in cell viability from 25% to
60% at 0.1 and 1 mM respectively, when compared with control unstimulated cells
(Figure 6B). This range of H2O2 concentrations was selected based on preliminary
experiments (Supplementary figure 1).
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FIGURE LEGENDS
Figure 2 Effect of hydrogen peroxide (H2O2) in the expression of miR-663a in oral
epithelial cells.
Oral epithelial cells (OKF6) (1x105/well) were exposed to different concentrations
of H2O2 for 24h and miR-663a expression determined by qRT-PCR. Cells exposed
to S. gordonii [1:5] were used as positive control &p≤0.05 bacteria or H2O2 vs.
Control. The mean ± Standard deviation of three replicates from each treatment
condition from two independent experiments is shown.
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Figure 3 Effect of Catalase in H2O2- and S. gordonii (Sg)-induced miR-663a
expression after 24h in oral epithelial cells.
Oral epithelial cells (OKF6) (1x105/well) were exposed to S. gordonii (Sg) [1:5] or
0.5 mM H2O2 for 24h in presence or absence of catalase (10U and 100U), and
miR-663a expression determined by qRT-PCR. &p≤0.05 Sg or H2O2 vs.
corresponding Mock groups; *p≤0.05 Catalase-treated vs. Media on each group.
The mean ± Standard deviation of three replicates from each treatment condition
from two independent experiments is shown.
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Figure 4 Effect of oral streptococcal species in miR-663a expression.
Oral epithelial cells (OKF6) (1x105/well) were exposed to oral streptococci H2O2
producers (S. gordonii and S. sanguinis) and non-producers (S. mutans and S.
salivarius) [MOIs 1:5 and 1:50] for 24h and miR-663a expression determined by
qRT-PCR. &p≤0.05 bacteria vs. Mock. The mean ± Standard deviation of three
replicates from each treatment condition from two independent experiments is
shown.
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Figure 5 Effect of Catalase in rescuing A. naeslundii (An)-induced CCL20
expression inhibited by S. gordonii and S. sanguinis.
Oral epithelial cells (OKF6) (1x105/well) were exposed to A. naeslundii (An) [1:50]
alone or with S. gordonii (Sg) or S. sanguinis (Ss) [1:5, 1:50] in presence or
absence of Catalase (10U or 100U) for 24h and CCL20 levels determined in cell
supernatants by ELISA. &p≤0.05 Media/Mock vs. other treatments. *p≤0.05
Media/An vs Sg+An or Ss+An. The mean ± Standard deviation of three replicates
from each treatment condition from two independent experiments is shown.
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Figure 6 Cell viability of oral epithelial cells exposed to oral bacteria or Hydrogen
Peroxide (H2O2).
Oral epithelial cells (OKF6) (1x105/well) were exposed to (A) different MOIs of
oral streptococci or (B) different concentrations of H2O2 for 24 hours. Cell viability
was determined through trypan blue exclusion using the Lifestyle Cell Counting
(Countess II FL Life Technologies, Thermo Scientific Technologies, USA). The
means ± Standard deviations of three replicates from each treatment condition
from two independent experiments are shown. *p≤0.05 bacteria- or H2O2-treated
groups vs. Control unstimulated cells.
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Figure 7 Preliminary experiments of cell viability in oral epithelial cells exposed to
Hydrogen Peroxide (H2O2).
Oral epithelial cells (OKF6) were exposed to different concentrations of H 2O2 for
24 hours. First, a range of H2O2 previously tested in vitro with human oral cells by
other groups was evaluated [1-10 mM]. In a second experiment an adjusted
range of H2O2 concentrations was evaluated showing that any effect in OEC
viability could be between 0.1 and 1 mM. Cell viability was determined through
trypan blue exclusion using the Lifestyle Cell Counting (Countess II FL Life
Technologies, Thermo Scientific Technologies, USA). The means ± Standard
deviations of three replicates from each treatment condition are shown.
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Chapter 8: DISCUSSION AND CONCLUSIONS
The mechanisms by which commensal bacteria regulates oral pathologic
inflammation (e.g., periodontitis) remain unknown. A better understanding of these
bacteria-associated

anti-inflammatory

mechanisms

could

provide

future

opportunities to prevent periodontal disease. Our lab has recently found that the
oral commensal bacteria S. gordonii up-regulates the expression of miR-663a in
oral epithelial cells (OECs), and this miRNA was able to decrease oral pathogeninduced CCL20 expression. This is relevant given the significant role of CCL20
regulating T-helper 17 (Th17) and T-regulatory (Treg) cell responses at mucosal
surfaces [87, 92, 142, 143], which are involved in the pathogenesis of soft and
bone destruction occurring in periodontal disease.
Based on the above findings, the ability of S. gordonii to produce hydrogen
peroxide (H2O2), and previous studies showing that H 2O2 stimulates miRNA
expression [144], the central question of this study was whether H 2O2 produced by
S. gordonii was involved in miR-663a and CCL20 expression in oral epithelial cells
(OECs). To address this question, we tested in vitro in human OECs (OKF6) the
effect of H2O2 as well as H2O2-producer or non-producer oral streptococcal species
in the expression of miR-663a and CCL20.
Initial treatment of OECs with H 2O2 enhanced expression of miR-663a,
similarly to the effect of S. gordonii. This response was about 8-9 times higher in
cells exposed to H2O2 compared to S. gordonii treatment. These findings are
consistent with previous studies showing the ability of H 2O2 to stimulate the
expression of specific miRNAs in other cell types (e.g., vascular smooth muscle

38

cell), although using significantly higher H2O2 concentrations between 10-200 µM
[144]. Biologically relevant H2O2 concentrations that bacteria normally encounter
are usually in the nanomolar to lower millimolar range, from 0.51 mmol/L up to 7
mmol/L reported for streptococci although those measurements were mostly
performed in batch cultures that may not be reflective of the normal H2O2 capacity
of streptococcal biofilms [145-148], like the concentrations evaluated in this study
(i.e., 0.1-1 mM), which could be more biologically relevant for specific host cell
responses.
Accurate measures of H2O2 produced by bacteria are challenging. Liu, et.
al., quantified the concentration of H2O2 produced by S. gordonii in the presence
of glucose using scanning electrochemical microscopy (SECM), a technique that
can scan over a substrate in the x-y direction and thus is able to record a unique
spatial concentration profile over a surface and has been used in other biological
systems to measure the local concentration over soft biological samples and for
imaging [149-151]. They detected ranges 0.4 mM-1.6 mM H2O2, depending on
the distance of the sensing tip from the biofilm, and time duration, because it takes
a much longer time to build up detectable H2O2 concentrations.
To determine whether H2O2 produced by S. gordonii is involved in miR-663a
expression in OECs, we exposed cells to S. gordonii either in presence or absence
of the enzyme catalase. Catalase is a highly efficient enzyme that is widely
expressed in peroxisomes, decomposes hydrogen peroxide and also inhibits the
SpxB gene expressing the oxidant formation [50, 152]. As expected, presence of
catalase significantly decreased S. gordonii-induced miR-663a expression in a
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dose-response manner. However, even higher catalase concentrations did not
completely abrogate miR-663a expression. This suggests that S. gordoniiproduced H2O2 is involved in up-regulation of miR-663a in OECs. Likely, the
amounts of H2O2 produced by S. gordonii under these experimental conditions
could be higher than 0.5 mM given that similar amounts of H 2O2 were completely
abrogated by the same catalase concentrations. The mechanisms by which H2O2
could be enhancing miR-663a expression in OECs remain to be determined.
Perhaps, the use of a more specific method to analyze the role of H2O2 produced
by S. gordonii in miR663a expression such as a SpxB knockout strain would allow
to determine if indeed, H2O2 or some other factors produced by S. gordonii could
also be contributing to this response.
H2O2 can serve as messenger to carry a redox signal from the site of its
generation to a target site and is considered most suitable for redox signaling [60,
153].

H2O2 also modulates the activity of transcription factors (e.g., NF-κB,

NOTCH, TP53) in mammalian cells [153]. Different patterns of p53-regulated gene
expression are initiated in response to different levels of H 2O2. We have found that
miR-663a targets the transcription factor JunB in OECs, which has also been
shown to regulate chemokine expression. Thus, the potential activation of JunB by
H2O2 could be regulated through miR-663a. For example, antioxidants are induced
in response to low levels of H2O2, where they lower ROS levels and hence, protect
the cell from DNA damage, while higher levels also stimulate the expression of
pro-oxidants involved in apoptosis [57]. The potential role of these cell signaling
pathways in miR-663a expression by OECs needs to be explored in future studies.
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Streptococci are one of the most abundant oral microbiome bacterial
species normally colonizing the oral cavity. Among these, bacterial species from
the mitis group such as S. gordonii, are strong producers of H2O2 [48]. Thus, other
bacterial species from the S. mitis group would be able to enhance miR663a
expression; nevertheless, streptococcal species from other groups (e.g., group
mutans or group salivarius) would fail to do it. Consistent with this hypothesis, only
S. gordonii and S. sanguinis from mitis group were able to increase miR-663a in
OECs in comparison to S. mutans and S. salivarius, which did not stimulate miR663 expression. The ability of some oral streptococci to produce H 2O2 has been
associated with bacterial killing or regulating the growth of other bacterial species
within the biofilms [53]. For example, in the oral biofilm, naturally produced H 2O2
crosses the bacterial membrane of producer cells, containing pyruvate oxidase
(spxB) gene, and is released into the environment where it can influence
neighboring cells and ultimately oral biofilm ecology [53]. SpxB-positive bacterial
species are expected to play a particularly important role in early biofilm
development, as streptococci comprise significant fractions of newly formed oral
biofilms and these biofilms contain significantly higher oxygen concentrations
compared with older, mature biofilms [154, 155]. In addition to their antibacterial
properties, this group of oral bacteria could also be specifically stimulating the
expression of miRNAs such as miR-663a to modulate host epithelial inflammatory
responses.
Although, several studies suggest that H2O2 can influence signaling
pathways that induce some proinflammatory responses [58-60], most recently, it
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has been demonstrated that beyond the conventional view of reactive oxygen
species as drivers of inflammation, H2O2 plays a significant role in host modulation
by inhibiting inflammasome responses at respiratory mucosal surfaces [68]. Thus,
specific H2O2 levels produced by oral streptococcal species could be regulating
pathologic oral inflammatory responses triggered by pathogenic/pro-inflammatory
bacteria. [156]. The effect of H2O2 in host cells seems to be concentrationdependent. For example, hydrogen peroxide has concentration-dependent effects
in the conjugation of mammalian proteins to the SUMO ubiquitin-like modifier.
SUMOylation is an important regulator of the localization, activity, and stability of
many proteins, and thus the concentration-dependent regulation of this protein
modification may be important to ensure the appropriate biological response to
increasing levels of H2O2 [50]. Concentrations of H2O2 such as those generated by
activated macrophages inhibit conjugation of SUMO and hence reduce
SUMOylation.Higher H2O2 concentrations (e.g., 100 mM) inhibited conjugation of
SUMO, causing an increase in the levels of SUMOylation [157-160].

Consistent with the above hypothesis, ongoing experiments in our lab
showed that S. gordonii challenge or transfection of OECs with miR-663a
downregulated CCL20 expression stimulated by A. naeslundii. Given that
expression of miR663a was induced by H2O2 in OECs and catalase abrogated that
effect, we hypothesized that H2O2 produced by S. gordonii was involved in their
ability to reduce A. naeslundii-induced CCL20. As expected, decrease in A.
naeslundii-stimulated CCL20 secretion into OEC supernatants induced by S.
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gordonii, was rescued by the presence of catalase. Whether rescue of A.
naeslundii-induced CCL20 blocked by S. gordonii with catalase involves downregulation of miR-663a needs to be determined; however, we found that S.
gordonii-induced miR-663a expression was significantly decreased by catalase.
Of note, similar responses were observed with S. sanguinis, another oral H2O2
producer. Thus, it is possible that oral streptococci H 2O2 producers such as S.
gordonii and S. sanguinis could be regulating CCL20 expression induced by oral
pathogenic bacteria in OECs through miRNAs such as miR663a. This is an
important observation, since increased levels of CCL20/MIP3α in gingival epithelial
cells and microvascular endothelial cells as well as a massive infiltration of CCR6expressing cells have been associated with periodontal disease [87]. Therefore,
presence of streptococci species producing H 2O2 as part of the normal oral
microbiome in a symbiotic environment would be critical to maintain homeostasis
and oral health. In contrast, reduction in the abundance of these symbionts, during
oral

dysbiosis

induced

by

environmental

(e.g.,

smoking),

host

(e.g.,

Immunodeficiencies), or oral pathogens (e.g., P. gingivalis), could be contributing
to enhance oral inflammation through variation in the levels of specific chemokines
such as CCL20. Similar CCL20 responses were observed in oral epithelial cell
lysates, which suggests that regulation of the expression of this chemokine could
involve

miR-663a-mediated

transcriptional

and/or

post-transcriptional

mechanisms, but not CCL20 secretion alterations.
Concentrations of H2O2 and S. sanguinis with the ability to increase miR663a expression, reduced about 40% the cell viability of OECs. The potential of
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miR-663a to regulate cell death and proliferation have been reported in several
cancers (e.g., breast, renal carcinoma) with different outcomes, either increasing
or decreasing cell death and proliferation, depending on the type of cancer [161,
162]. Future studies investigating the role of miR663a in OEC apoptosis are
warranted.
A body of evidence supports that reactive oxygen species (ROS) such as
H2O2 are involved in the pathogenesis of several inflammatory diseases such as
atherosclerosis, hypertension, diabetic complications, etc., by modulating the
expression of genes associated with cell differentiation, proliferation, migration,
and apoptosis [163-165]. However, emerging evidence indicates that specific
levels of H2O2 contribute to regulate bacterial growth of oral pathogens normally
colonizing mucosal surfaces in low numbers and reducing inflammation [166-169].
The mechanisms through which oral commensal bacteria prevent pathologic oral
inflammatory responses remain unknown. In this study, we have identified a new
H2O2-mediated regulatory mechanism through which oral streptococcal species
could be attenuating host CCL20-mediated pro-inflammatory epithelial responses
through miRNAs, thus contributing to maintain an oral and periodontal symbiotic
environment. Future studies using organotypic cultures and biofilm models as well
as in vivo mice models would be needed to validate the functional effect of
miR663a in modulating the recruitment of Th17 and Treg cells by oral pathogens
and soft and bone tissue destruction, both hallmarks of periodontal disease.
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